YM BioSciences Inc.Mississauga, ON Canada
Company Description
The "YM" in BioSciences might stand for "young and modern" as once the letters of YM magazine did. The firm was founded in 1994 to develop a variety of new anti-cancer technologies by licensing potential products already in stages of development. The biotech's drug candidates could help patients with lung, breast, colorectal, brain, head and neck, and other types of cancer. YM BioSciences' pipeline includes nimotuzumab (formerly TheraCIM), a monoclonal antibody therapy designed to enhance the effects of radiation treatment in cancer patients, and AeroLEF, a treatment for moderate to severe pain including cancer pain.
| 5045 Orbitor Dr., Bldg. 11, Ste. 400 | Phone: +1-905-6299761 | http://www.ymbiosciences.com |
| Mississauga, ON L4W 4Y4 | Fax: +1-905-6294959 | 
Map This Company |
| Canada |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
YM BioSciences Inc. Rankings
Executives
| 15 executives listed for YM BioSciences Inc.'s Mississauga, ON location. | ||
| Chairman | David Allan | |
|---|---|---|
| VP Finance and Administration | Leonard Vernon | |
| VP Corporate Development; General Manager, IntelliMab | Sean Thompson | |
Financials
| Company Type | PublicHeadquarters |
|---|---|
| Fiscal Year-End | June |
| 2011 Employees | 39 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on YM BioSciences Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
